Zentalis Pharmaceuticals, Inc. (ZNTL)
3.74
-0.06
(-1.58%)
USD |
NASDAQ |
Aug 31, 15:07
Zentalis Pharmaceuticals Free Cash Flow : -128.13M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -128.13M |
| March 31, 2026 | -125.60M |
| December 31, 2025 | -125.25M |
| September 30, 2025 | -134.01M |
| June 30, 2025 | -151.09M |
| March 31, 2025 | -151.70M |
| December 31, 2024 | -171.08M |
| September 30, 2024 | -172.15M |
| June 30, 2024 | -166.86M |
| March 31, 2024 | -211.14M |
| December 31, 2023 | -208.40M |
| September 30, 2023 | -205.12M |
| June 30, 2023 | -201.22M |
| March 31, 2023 | -164.94M |
| Date | Value |
|---|---|
| December 31, 2022 | -166.30M |
| September 30, 2022 | -168.02M |
| June 30, 2022 | -169.31M |
| March 31, 2022 | -172.94M |
| December 31, 2021 | -160.20M |
| September 30, 2021 | -149.01M |
| June 30, 2021 | -133.46M |
| March 31, 2021 | -108.59M |
| December 31, 2020 | -87.58M |
| September 30, 2020 | -72.79M |
| June 30, 2020 | -62.28M |
| March 31, 2020 | -47.35M |
| December 31, 2019 | -39.50M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ARS Pharmaceuticals, Inc. | -196.60M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -37.24M |
| Cash from Investing (Quarterly) | 30.02M |
| Cash from Financing (Quarterly) | 0.065M |
| Free Cash Flow Per Share (Quarterly) | -0.5221 |
| Free Cash Flow to Equity (Quarterly) | -36.28M |
| Free Cash Flow to Firm (Quarterly) | -37.24M |
| Free Cash Flow Yield | -48.02% |